25 September 2018

World Contraception Day 2018: Improving Women's Welfare through Information, Education and Communication (IEC) on Reproductive Health and Family Planning.

“10 years of Bayer Oral Contraceptive Ambassadors program in Indonesia”

  • IEC: crucial for women’s reproductive health and family planning
  • Contraception can help women achieve a better life
  • 10 years of Bayer Oral Contraceptive Ambassadors program in Indonesia: exemplary partnership between Bayer and Indonesian Population and Family Planning Board, with support and participation by the Indonesian Midwives Association via the national family planning Blue Circle program.


Jakarta, 25 September 2018 World Contraception Day (WCD) is commemorated every September 26 and this year PT. Bayer Indonesia once again advocates the importance of bolstering women's knowledge on reproductive health and family planning through IEC (Information, Education, Communication). Ensuring access and information to contraception and services can lead to socio-economics benefits: as it empowers women and helps them and their partners to determine the spacing and the number of their children, enable women to complete their best education and increase women's autonomy in their homes and strengthen their economies1.


With the current population of Indonesia is at 265 million, 10,864,2002 million girls annually grow up to become young women and young mothers. Meanwhile, 2013 RISKESDAS (National Basic Health Research) indicates that there is a slight increase in contraceptive use, from 55.8 percent (2010) to 59.7 percent (2013) and at the same time, there is a decrease in Total Fertility Rate (TFR) from 2.6 children per women in 2012 to 2.4 in 2017.


Bayer together with BKKBN advocate for the bolstering of IEC on reproductive health for women and their families to ensure that contraceptive use continue to grow in Indonesia and that the national TFR 2.3 target (RENSTRA 2015-2019) is achieved. To help promote IEC on reproductive health, Bayer is committed to continue its Bayer Oral Contraceptive Ambassadors program in Indonesia. The program, which has entered its 10th year is an exemplary partnership between Bayer and Indonesian Population and Family Planning Board, with support and participation by the Indonesian Midwives Association via the national family planning Blue Circle program. Bayer has supported family planning programs in Indonesia for more than 30 years.


PT Bayer Indonesia President Director, Angel Michael Evangelista, in his remarks said, "Family planning and education are important steps to break the cycle of poverty – both for women and their families. For more than 50 years, Bayer has supported family planning program in more than 130 countries. In Indonesia, Bayer has been partnering with the government for more than thirty years in the Blue Circle program. As a Life Science company and worldwide leader of the oral contraceptive market, Bayer strongly supports the availability of access to information, education and communication for women in Indonesia about reproductive health and contraception so that they can make decisions independently and appropriately for their own health which is of course very beneficial to health and family welfare in Indonesia. OC Ambassadors are a tangible form of Bayer's commitment this year to enter its 10-year anniversary. With the presence of OC Ambassadors which currently number 360 midwives through 3,600 extension activities, it has been able to reach 108,000 women. "


Dr. dr. Andon Hestiantoro, SpOG (K), explained, "The population control approach through the use of contraception is an important global movement with the aim of improving women’s welfare and status.


Contraception use not only aids in birth control but also increases women's rights to decide when they are ready to get pregnant. Family planning helps empower women socially and allows them to have more time to seek information and education for themselves, which directly affect how well they can raise a healthy family."


"However, there are many barriers to increasing the use of contraception such as the misunderstanding that contraception can cause weight gain, religious beliefs and daily pills compliance and the possibility of misuse.Therefore, providing information and education to the public is critical, "he added.


He also underlined,”It is important to understand that even though TFR has decreased but the Indonesia population is still high. Therefore, participation and support from all parties is very important, including Government’s support in policy of contraception subsidy through BPJS. In addition, we also support the role and participation of private sector in helping women reachs a better quality of life, as Bayer Indonesia does through OC Ambassador’s program.”


The Chairwoman of the Indonesian Midwives Association (IBI), Dr. Emi Nurjasmi M. Kes. said, "Reproductive health services are the main tasks of IBI, ie contraceptive usage and counseling services. Midwives are front liners. They are not only fulfilling women's contraceptive needs, but also as agents of change, by conducting IEC for women. With IEC, women can manage, determine and maintain their health, their children and their family. "


She also added, "As part of implementing health services in Indonesia, we conduct regular training for midwives, both clinically and non-clinically in improving their qualities. With these efforts, we ensure that midwives are capable on their profession and also able to communicate well with a leadership. "


"We hope that the government will continue to inform and educate the public about the importance of reproductive health, especially for women through many channels. In addition, we also need support from government to improve the quality of the training especially for non-clinical training, "she concluded.

About World Contraception Day (WCD)

World Contraception Day takes place on September 26th every year. The annual worldwide campaign centers around a vision where every pregnancy is wanted. Launched in 2007, WCD’s mission is to improve awareness of contraception and to public to make informed choices on their sexual and reproductive health. World Contraception Day is supported by a coalition of 17 international Non-Governmental Organizations (NGOs), governmental organizations and scientific and medical societies with an interest in sexual and reproductive health and is sponsored by Bayer AG.


The Partners involved are:

  • Asia Pacific Council on Contraception (APCOC)
  • United States Agency for International Development (USAID)
  • The European Society of Contraception and Reproductive Health (ESC)
  • Pathfinder International
  • Centro Latino Americano de Salud Y Mujer (CELSAM)
  • Population Council
  • Deutsche Stiftung Weltbevoelkerung (DSW)
  • Family Planning 2020 (FP2020)
  • Marie Stopes International (MSI)
  • International Planned Parenthood Federation (IPPF)
  • Federation Internationale De Gynecologie Infantile Et Juvenile (FIGI)
  • United Nation Population Fund (UNFPA)
  • Every Women Every Child
  • Women Deliver
  • Population Services International (PSI)
  • EngenderHealth
  • 120 under Forty


Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.com or www.bayer.co.id.



Laksmi Prasvita

Head of Communications & Public Affairs PT Bayer Indonesia

Phone: +62-21-30491490

E-mail: laksmi.prasvita@bayer.com



Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com.  The company assumes no liability whatsoever to update these forward-looking statements or to conformthem to future events or developments.